» Authors » Jennifer H Kuo

Jennifer H Kuo

Explore the profile of Jennifer H Kuo including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 72
Citations 439
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hsu S, Kuo E, McManus C, Liou R, Lee J, Kuo J
World J Surg . 2025 Mar; PMID: 40044447
Background: Near-infrared autofluorescence (NIRAF) spectroscopy is an emerging adjunct for intraoperative parathyroid identification. However, its ability to differentiate between normocellular, hyperplastic, or adenomatous parathyroids remains unexplored. We hypothesize that parathyroid...
2.
3.
Schiazza A, McManus C, Hsu S, Kuo E, Lee J, Kuo J
Endocr Pract . 2024 Dec; 31(3):352-358. PMID: 39672541
Objective: The field of endocrine surgery has been expanding its minimally invasive techniques to treat a wide range of thyroid pathologies. Radiofrequency ablation (RFA) is one targeted thermal therapy that...
4.
Yeh R, Kuo J, Huang B, Shobeiri P, Lee J, Tay Y, et al.
Eur Radiol . 2024 Oct; 35(3):1325-1336. PMID: 39476058
Purpose: To train and validate machine learning-derived clinical decision algorithm (CDA) for the diagnosis of hyperfunctioning parathyroid glands using preoperative variables to facilitate surgical planning. Methods: This retrospective study included...
5.
Collins R, McManus C, Kuo E, Liou R, Lee J, Kuo J
Surgery . 2024 Oct; 177:108823. PMID: 39384472
Background: Radiofrequency ablation is an effective minimally invasive technique for benign thyroid nodules, with European and Asian studies reporting improved quality of life following treatment. We aimed to assess the...
6.
Carlisle K, Talaie T, Khalid S, Turner D, Terhune J, Kuo J, et al.
Clin Endocrinol (Oxf) . 2024 Oct; 102(1):91-100. PMID: 39351890
Objective: Autonomously functioning thyroid nodules (AFTN) can be treated with antithyroid drugs, radioactive iodine (RAI), thyroid lobectomy or radiofrequency ablation (RFA). Although surgery is most definitive, some patients require lifelong...
7.
Ryu Y, Hsu S, Kuo E, Liou R, McManus C, Lee J, et al.
Am J Surg . 2024 Aug; 241:115929. PMID: 39217057
Background: The efficacy of radiofrequency ablation (RFA) in treating thyroid nodules with indeterminate cytology remains less studied. The objective of this study was to determine the efficacy of RFA in...
8.
Lam A, Holt E, Ridouani F, Tuttle R, Tufano R, Park A, et al.
J Vasc Interv Radiol . 2024 Aug; 35(12):1752-1759. PMID: 39153659
The role of locoregional therapy in the management of thyroid pathology is rapidly evolving. The Society of Interventional Radiology (SIR) Foundation commissioned an international research consensus panel consisting of physicians...
9.
Chan S, Betcher M, Kuo E, McManus C, Lee J, Kuo J
Am J Surg . 2024 Jun; 237:115793. PMID: 38879355
Background: Radiofrequency ablation (RFA) effectively reduces volume and improves symptoms of benign, non-functioning thyroid nodules (NFTNs). Given RFA's unclear impact on thyroid function, we examined post-RFA trends in thyroid hormones...
10.
Stillman M, Kuo E, Liou R, Almuqate A, Virk R, Lee J, et al.
Thyroid . 2024 Mar; 34(4):460-466. PMID: 38468547
Molecular testing (MT) has become standard practice to more accurately rule out malignancy in indeterminate Bethesda III (BIII) thyroid lesions. We sought to assess the adoption of this technology and...